News | Radial Access | December 30, 2019

Merit Medical Announces its EVOlution in Radial Hemostasis in Europe

The product has FDA clearance in the U.S. and CE Mark approval in the EU for use in diagnostic cardiac catheterisation procedures and percutaneous coronary interventions


December 30, 2019 — Merit Medical Systems Inc., a leading manufacturer of proprietary devices used primarily in cardiology, radiology, oncology and endoscopy, announces the commercial launch of the PreludeSYNC EVO radial compression device in European, Middle Eastern and African markets.

The product has FDA clearance in the U.S. and CE Mark approval in the EU for use in diagnostic cardiac catheterisation procedures and percutaneous coronary interventions.

Merit’s PreludeSYNC EVO is a sterile, single-use, disposable device used to assist in gaining haemostasis of the arterial percutaneous access site following catheterisation procedures.

“PreludeSYNC EVO adds to our extensive line of radial compression devices that support PCI from start to finish. It was developed to meet the evolving clinical and health economic needs of physicians, administrators and cath lab teams around the globe. Our intent with PreludeSYNC EVO, the latest innovation in our premium cardiology product portfolio, is to provide physicians with even more procedural clarity and uniformity and their patients with safety and comfort,” said Fred P. Lampropoulos, Merit Medical’s Founder, Chairman, and Chief Executive Officer

The need for clarity and uniformity is fulfilled by PreludeSYNC EVO’s large clear window area with unobstructed site visibility. It is also optimised for diffuse and uniform balloon pressure. The safety features include a specialised connection and Slip-n-Lock cap which secures the syringe during inflation and deflation. A soft comfortable band, which is easy to secure, adjust and clean, is available in 24 and 29 cm sizes.

The PreludeSYNC EVO is immediately available in the EU, with registration coming in Middle East and Africa. 

For more information: www.merit.com


Related Content

News | Radial Access

May 19, 2022 — Initial findings from the Distal versus Proximal Radial Artery Access for Cardiac Catheterization and ...

Home May 19, 2022
Home
Videos | Radial Access

Arnold Seto, M.D., MPA, FSCAI, chief of cardiology, Long Beach Veterans Affairs Medical Center and director ...

Home May 06, 2021
Home
News | Radial Access | Dave Fornell, Editor

April 28, 2021 — A new study reveals the use of a potassium ferrate hemostatic patch (PFHP) reduces the time to ...

Home April 28, 2021
Home
Videos | Radial Access

Jordan G. Safirstein, M.D., FACC, FSCAI, director of transradial catheterization for Atlantic Health System’s Morristown ...

Home October 07, 2020
Home
Videos | Radial Access

Atlantic Health System’s Morristown Medical Center has opened one of the region’s first radial lounges in its Gagnon ...

Home September 11, 2020
Home
News | Radial Access

August 25, 2020 – Atlantic Health System’s Morristown Medical Center has opened one of the region’s first radial lounges ...

Home August 25, 2020
Home
Feature | Radial Access | Dave Fornell, Editor

Transradial access for percutaneous coronary intervention (PCI) in the United States has grown rapidly over the past 20 ...

Home February 14, 2020
Home
News | Radial Access

January 15, 2020 — The Society for Cardiovascular Angiography and Interventions (SCAI) released an updated expert ...

Home January 15, 2020
Home
Feature | Radial Access | Enrique Flores, M.D., RPVI

Interest in distal radial artery access (DRA) is growing rapidly. Among the benefits of DRA are the low risk of entry ...

Home November 21, 2019
Home
Videos | Radial Access

Sunil Rao, M.D., chief of cardiology, Durham VA Health System and a professor at Duke University, and Prashant Kaul, M.D ...

Home October 22, 2019
Home
Subscribe Now